Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
This study is currently recruiting participants.
Verified March 2013 by University of Alabama at Birmingham
Information provided by (Responsible Party):
Charles Mel Wilcox, MD, University of Alabama at Birmingham
First received: January 24, 2008
Last updated: March 13, 2013
Last verified: March 2013
The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.
||Observational Model: Case Control
Time Perspective: Prospective
||Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
Primary Outcome Measures:
- Evaluation of current clinical practice for patients with idiopathic pancreatitis [ Time Frame: 3 hours ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||October 2013 (Final data collection date for primary outcome measure)
The study evaluates the role of endoscopic ultrasonography, given that the minimally invasive procedures can diagnosis gallbladder disease as well as pancreatitis abnormalities.
|Ages Eligible for Study:
||19 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Men and women diagnosed with unexplained pancreatitis.
- All patients referred to the principal investigator for unexplained pancreatitis will be enrolled.
- There are no gender nor racial exclusion.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00609726
|Contact: Charles M Wilcox, M.D.
|University of Alabama
|Birmingham, Alabama, United States, 35294 |
Charles Mel Wilcox, MD
||Charles M Wilcox, M.D.
||University of Alabama at Birmingham
No publications provided
||Charles Mel Wilcox, MD, Principal Investigator, University of Alabama at Birmingham
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 24, 2008
||March 13, 2013
||United States: Institutional Review Board
Keywords provided by University of Alabama at Birmingham:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 16, 2013
Biliary Tract Diseases
Digestive System Diseases